Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,463 INR | +0.70% | -1.14% | +17.35% |
May. 31 | Cipla's Global Chief Technology Officer Retires | MT |
May. 30 | India's pharma export sales to grow faster this year, trade body says | RE |
Sales 2024 | 258B 3.09B | Sales 2025 * | 280B 3.35B | Capitalization | 1,173B 14.05B |
---|---|---|---|---|---|
Net income 2024 | 41.22B 494M | Net income 2025 * | 46.75B 560M | EV / Sales 2024 | 4.69 x |
Net cash position 2024 * | 55.83B 669M | Net cash position 2025 * | 52.75B 632M | EV / Sales 2025 * | 4 x |
P/E ratio 2024 |
29.3
x | P/E ratio 2025 * |
25.2
x | Employees | 32,323 |
Yield 2024 * |
0.58% | Yield 2025 * |
0.68% | Free-Float | 67.03% |
Latest transcript on Cipla Limited
1 day | -0.79% | ||
1 week | -2.61% | ||
Current month | -0.44% | ||
1 month | +1.23% | ||
3 months | -2.08% | ||
6 months | +18.45% | ||
Current year | +15.61% |
Managers | Title | Age | Since |
---|---|---|---|
Umang Vohra
CEO | Chief Executive Officer | 52 | 15-09-30 |
Ashish Adukia
DFI | Director of Finance/CFO | - | 22-08-15 |
Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ashok K. Sinha
BRD | Director/Board Member | 72 | 13-07-15 |
Chairman | 87 | 72-07-20 | |
Director/Board Member | 83 | 77-08-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.99% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 1,463 | +0.70% | 2 049 577 |
24-06-03 | 1,452 | +0.36% | 1,335,614 |
24-05-31 | 1,447 | -1.32% | 3,270,743 |
24-05-30 | 1,467 | -1.80% | 1,732,140 |
24-05-29 | 1,494 | +0.95% | 1,607,691 |
Delayed Quote NSE India S.E., June 04, 2024 at 03:05 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.61% | 14.11B | |
+13.58% | 41.95B | |
+22.20% | 22.53B | |
+14.75% | 14.91B | |
+39.80% | 12.5B | |
-9.44% | 6.75B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.55% | 5.6B | |
+4.00% | 4.95B |
- Stock Market
- Equities
- CIPLA Stock